Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03698149 · ClinicalTrials.gov registry record · NA

ECoG BMI for Motor and Speech Control

A NA study of Stroke and Multiple Sclerosis, sponsored by Karunesh Ganguly.

Recruiting
Registry status
NA
Development phase
3
Enrollment target
1
Study location

NCT03698149 is a NA study of Stroke and Multiple Sclerosis that is actively recruiting participants, run by Karunesh Ganguly. The registered enrollment target is 3 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03698149, a NA study of Stroke and Multiple Sclerosis, is actively recruiting participants, sponsored by Karunesh Ganguly.

RECRUITING
Registry status
NA
Development phase
3 participants
Enrollment target
1
Study location

Study Summary

Test the feasibility of using electrocorticography (ECoG) signals to control complex devices for motor and speech control in adults severely affected by neurological disorders.

Interventions

  • DEVICE PMT/Blackrock Combination Device

Study Locations (1)

California

  • University of California San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2018-11-09
Est. Completion 2030-08-15
Phase NA

Sponsor

Karunesh Ganguly

1 total trials

What the Registry Record Tells You About NCT03698149

The ClinicalTrials.gov registry entry for NCT03698149 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Karunesh Ganguly, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which PMT/Blackrock Combination Device is the first listed.

NCT03698149 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03698149 about?

NCT03698149 is a clinical study titled "ECoG BMI for Motor and Speech Control". Test the feasibility of using electrocorticography (ECoG) signals to control complex devices for motor and speech control in adults severely affected by neurological disorders.

What is the current status of trial NCT03698149?

This trial is currently recruiting. It is a NA study. The enrollment target is 3 participants. The study started on 2018-11-09. Estimated completion is 2030-08-15.

What conditions does trial NCT03698149 study?

This clinical trial studies the following conditions: Stroke, Multiple Sclerosis, ALS, SCI - Spinal Cord Injury, Muscular Dystrophies.

What interventions are being tested in trial NCT03698149?

The interventions under investigation include: PMT/Blackrock Combination Device (DEVICE).

Who is sponsoring clinical trial NCT03698149?

This trial is sponsored by Karunesh Ganguly, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03698149 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.